Sort
78,016 grants matching “breast cancer”
A Novel Anti-HER2/neu IgE for Breast Cancer Therapy
$592,761Manuel L Penichet · University Of California Los Angeles · R01 · FY2018 · CA
A Conversation Aid on Mammography Screening to Support Shared Decision Making between Clinicians and Women Aged 75 and Older
$592,758Mara A Schonberg · Beth Israel Deaconess Medical Center · R01 · FY2022 · AG
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis
$592,726John Alan Shepherd · University Of California, San Francisco · R01 · FY2015 · CA
MECHANISMS BEHIND HYPERCHOLESTEROLEMIA ASSOCIATED BREAST CANCER RISK AND PROGRESSION
$592,674Case Western Reserve University · · FY2013 · Department of Defense
Genetic and environmental interaction analyses and risk prediction modeling
$592,661Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · U19 · FY2010 · CA
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository
$592,642Chu Chen · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
$592,634Jenny C-N Chang · Methodist Hospital Research Institute · U01 · FY2023 · CA
Obesity, chemotherapy dosing, and breast cancer outcomes
$592,632Elizabeth David Kantor · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA
PLATELET AND CELL GROWTH--ROLE OF PDGF
$592,625Scripps Research Institute · R01 · FY2002 · HL
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
$592,593Lance L Munn · Massachusetts General Hospital · U01 · FY2024 · CA
MOUSE MODELS OF OVARIAN CANCER
$592,506Fox Chase Cancer Center · U01 · FY2000 · CA
MUTANT DNA-ACTIVATED KILLING SYSTEM FOR PRECISION BREAST CANCER THERAPY
$592,500University Of California, San Diego · · FY2025 · Defense Health Agency
MUTANT DNA-ACTIVATED KILLING SYSTEM FOR PRECISION BREAST CANCER THERAPY
$592,500University Of California, San Diego · · FY2025 · Defense Health Agency
A NOVEL ROLE OF EMMPRIN IN ACTIVATION OF CANCER-ASSOCIATED FIBROBLASTS IN BREAST CANCER
$592,500The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2011 · Department of the Army
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer
$592,455Joanna E Burdette · University Of Illinois At Chicago · R01 · FY2025 · CA
A MODELING-BASED PERSONALIZED SCREENING STRATEGY COMBINING CIRCULATING BIOMARKER AND IMAGING DATA FOR BREAST CANCER EARLY DETECTION
$592,436The Leland Stanford Junior University · · FY2018 · Department of the Army
Pediatric Severe Traumatic Brain Injury in Latin America â A Randomized Trial Comparing Two Management Protocols
$592,424Randall M Chesnut · University Of Washington · R01 · FY2022 · HD
Understanding the impacts of cancer therapy, high temperature and poor air quality on heart and lung health in breast cancer survivors.
$592,402Anne C Kirchhoff · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker
$592,393Caterina M Gallippi · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
THE UNIV OF PUERTO RICO COMPREHENSIVE CANCER CTR BREAST & CERVICAL EARLY DETECTIO
$592,349Reynold Eugenio Lopez-Enriquez · University Of Puerto Rico Med Sciences · U58 · FY2008 · DP
High Content Representation and Association of 3D Cell Culture Models
$592,332Bahram A. Parvin · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2014 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$592,289William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Mobile Device CBT for Chemotherapy-Related Cognitive Dysfunction: A Multi-Center Randomized Controlled Trial
$592,271Robert J Ferguson · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Vanderbilt Network Lead Academic Participating Site for the NCTN
$592,247Jordan D Berlin · Vanderbilt University Medical Center · U10 · FY2017 · CA
Relationships between parity, breastfeeding and ER- breast cancer in African American women: Elucidating the biologic underpinnings at the molecular and cellular level.
$592,214Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA